Genus PLC
OTC:GENSF

Watchlist Manager
Genus PLC Logo
Genus PLC
OTC:GENSF
Watchlist
Price: 26.01 USD Market Closed
Market Cap: 1.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+8%
Revenue
Forecast
+4%
Operating Income
Forecast
+23%
Net Income
Forecast
+106%

Wall Street
Price Targets

GENSF Price Targets Summary
Genus PLC

Wall Street analysts forecast GENSF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENSF is 28.14 USD with a low forecast of 20.08 USD and a high forecast of 36.11 USD.

GENSF Lowest Forecast
Wall Street Target
20.08 USD
23% Downside
GENSF Average Forecast
Wall Street Target
28.14 USD
8% Upside
GENSF Highest Forecast
Wall Street Target
36.11 USD
39% Upside
Lowest
Price Target
20.08 USD
23% Downside
Average
Price Target
28.14 USD
8% Upside
Highest
Price Target
36.11 USD
39% Upside
Genus PLC Competitors:
Price Targets
1530
3SBio Inc
18% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Downside
CRSP
CRISPR Therapeutics AG
50% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
53% Upside
1530
3SBio Inc
18% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Downside
CRSP
CRISPR Therapeutics AG
50% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
53% Upside
VCYT
Veracyte Inc
76% Upside
HPHA
Heidelberg Pharma AG
186% Upside
ACAD
ACADIA Pharmaceuticals Inc
28% Upside
D
688192
Dizal Jiangsu Pharmaceutical Co Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Genus PLC

For the last 8 years the compound annual growth rate for Genus PLC's revenue is 7%. The projected CAGR for the next 4 years is 5%.

7%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Genus PLC

For the last 8 years the compound annual growth rate for Genus PLC's operating income is 4%. The projected CAGR for the next 4 years is 17%.

4%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Genus PLC

For the last 8 years the compound annual growth rate for Genus PLC's net income is -20%. The projected CAGR for the next 4 years is 81%.

-20%
Past Growth
81%
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

See Also

Summary
GENSF intrinsic value, competitors valuation, and company profile.
DCF Valuation
GENSF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GENSF stock valuation using valuation multiples.
Wall Street Estimates
GENSF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GENSF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENSF's stock price target?
Price Target
28.14 USD

According to Wall Street analysts, the average 1-year price target for GENSF is 28.14 USD with a low forecast of 20.08 USD and a high forecast of 36.11 USD.

What is Genus PLC's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Genus PLC's revenue is 7%. The projected CAGR for the next 4 years is 5%.

What is Genus PLC's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Genus PLC's operating income is 4%. The projected CAGR for the next 4 years is 17%.

What is Genus PLC's Net Income forecast?
Projected CAGR
81%

For the last 8 years the compound annual growth rate for Genus PLC's net income is -20%. The projected CAGR for the next 4 years is 81%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 268,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.